Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes
ABSTRACT Pregnancy in women with end‐stage kidney disease (ESKD) requiring dialysis remains high risk, with significant maternal and fetal complications. While fertility rates are markedly reduced in this population, advances in dialysis care and obstetric management have led to increasing reports of successful pregnancies.
Shreepriya Mangalgi, Silvi Shah
wiley +1 more source
Atypical Hemorrhagic Presentation of Neurocysticercosis in a Patient on Chronic Anticoagulation. [PDF]
Leon Figueredo E +5 more
europepmc +1 more source
A case of propylthiouracil induced antineutrophil cytoplasmic antibody associated vasculopathy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nikhil Dwivedi +2 more
wiley +1 more source
In patients with cirrhosis and a first portal vein thrombosis treated with intravenous anticoagulant therapy, the 3‐year cumulative rates of liver‐related events were 56.7% and 75.5% in the effective and ineffective groups, respectively. A good radiological response was associated with fewer liver‐related hospitalizations.
Atsushi Maeda +19 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber +3 more
wiley +1 more source
Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers. [PDF]
Kumar R +6 more
europepmc +1 more source
Global renal infarction from main renal artery occlusion in under-anticoagulated atrial fibrillation: A case report. [PDF]
Tuin A +6 more
europepmc +1 more source
NAPaR : European non-interventional post-authorisation safety study of pattern of use and safety of Nordic aprotinin [PDF]
De Hert, Stefan +4 more
core
Portal Vein Thrombosis Due to Concomitant Cytomegalovirus and Epstein-Barr Virus Infection: An Underestimated Complication. [PDF]
AlQahtani SY.
europepmc +1 more source
Catastrophic antiphospholipid syndrome in a 39-year-old woman. [PDF]
Salih A, Altorok N, Assaly R, Safi F.
europepmc +1 more source

